Bunny Saberwal, Adam Ioannou, Wei Y. Lim, Anne-Marie Beirne, Anthony W. Chow, Dimitris Tousoulis, Syed Ahsan and Nikolaos Papageorgiou* Pages 2715 - 2724 ( 10 )
Atrial fibrillation (AF) is a common arrhythmia which carries a significant risk of stroke. Secondary prevention, particularly in the acute phase of stroke with anti-thrombotic therapy, has not been validated. The aim of this review is to evaluate the available evidence on the use of antithrombotic therapy in patients with recent stroke who have AF, and suggest a treatment algorithm for the various time points, taking into account both the bleeding and thrombosis risks posed at each stage.
Atrial Fibrillation (AF), acute phase in stroke, anti-thrombotic, anticoagulation, treatment algorithm, arrhythmia.
Electrophysiology Department, Barts Heart Centre, St. Bartholomew’s Hospital, London EC1A 7BE, Royal Free Hospital, London NW3 2QG, Electrophysiology Department, Barts Heart Centre, St. Bartholomew’s Hospital, London EC1A 7BE, Electrophysiology Department, Barts Heart Centre, St. Bartholomew’s Hospital, London EC1A 7BE, Electrophysiology Department, Barts Heart Centre, St. Bartholomew’s Hospital, London EC1A 7BE, First Cardiology Department, Hippokration Hospital, Athens University Medical School, Athens, Electrophysiology Department, Barts Heart Centre, St. Bartholomew’s Hospital, London EC1A 7BE, Electrophysiology Department, Barts Heart Centre, St. Bartholomew’s Hospital, London EC1A 7BE